Related Experiment Video
Updated: Jul 30, 2025

06:08
Quantification of Hypopigmentation Activity In Vitro
Published on: March 6, 2019
11.4K
Raspberry ketone glucoside suppresses melanin synthesis through IL6/JAK1/STAT3 signal pathway
1School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, China. hartzhao@163.com.
Summary
Raspberry ketone glucoside (RKG) demonstrates significant skin whitening effects by inhibiting melanogenesis. RKG activates the IL6/JAK1/STAT3 pathway, reducing melanin production in cellular and zebrafish models.
Area of Science:
- Biochemistry
- Dermatology
- Molecular Biology
Background:
- Melanogenesis is a complex process regulated by various signaling pathways.
- Inhibiting melanogenesis is a key strategy for developing skin-whitening agents.
- Raspberry ketone glucoside (RKG) is a natural compound with potential cosmetic applications.
Purpose of the Study:
- To evaluate the anti-melanogenic activity of raspberry ketone glucoside (RKG).
- To elucidate the molecular mechanisms underlying RKG's effect on melanogenesis.
Main Methods:
- In vitro studies using B16F10 melanoma cells and mushroom tyrosinase assay.
- In vivo studies using a zebrafish model.
- RNA-sequencing (RNA-seq) and quantitative real-time PCR (qRT-PCR) for pathway analysis.
- Inhibitor assays targeting specific signaling molecules and gene expression analysis.
Main Results:
- RKG significantly inhibited melanogenesis in B16F10 cells and zebrafish.
- RNA-seq and qRT-PCR revealed RKG activates the IL6/JAK1/STAT3 pathway.
- RKG suppressed the expression of key melanogenesis genes: MITFa, TYR, and TYRP1a.
- Inhibitor studies confirmed the involvement of the IL6/JAK1/STAT3 pathway in RKG's anti-melanogenic effect.
Conclusions:
- RKG exhibits potent skin-whitening properties.
- RKG inhibits melanogenesis by activating the IL6/JAK1/STAT3 signaling pathway.
- RKG reduces melanin production through the downregulation of MITFa and its downstream targets TYR and TYRP1a.
Related Concept Videos
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
NF-κB-dependent Signaling Pathway
7.6K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.6K
TGF - β Signaling Pathway
7.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K

